Spider-venom peptides as therapeutics.

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Spiders are highly successful terrestrial predators, utilizing silk and complex venoms for prey capture.
• Spider venoms contain numerous disulfide-rich peptides with high affinity for ion channels and receptors.
• Over 10 million bioactive peptides are predicted in spider venoms, presenting a significant resource for pharmaceutical research.

Purpose of the Study:

• To review the structure and pharmacology of spider-venom peptides.
• To highlight their therapeutic potential in drug discovery.
• To discuss applications in treating various pathophysiological conditions.

Main Methods:

• Literature review of spider venom composition and peptide pharmacology.
• Analysis of peptide structures and their interactions with biological targets.
• Examination of preclinical and clinical studies on venom-derived therapeutics.

Main Results:

• Spider venoms are dominated by disulfide-rich peptides targeting ion channels and receptors.
• These peptides exhibit diverse pharmacological activities.
• Numerous venom peptides are under investigation as therapeutic leads.

Conclusions:

• Spider venoms represent a rich source of novel drug candidates.
• Therapeutic applications span cardiovascular disorders, chronic pain, inflammation, and erectile dysfunction.
• Further research into spider venom peptides can yield significant advancements in medicine.